Clinical Implications of the STAR*D Trial.

Article Details

Citation
Copy to clipboard

John Rush A, Jain SB

Clinical Implications of the STAR*D Trial.

Handb Exp Pharmacol. 2018 Sep 11. doi: 10.1007/164_2018_153.

PubMed ID
30203327 [ View in PubMed
]
Abstract

This chapter provides a synopsis of the clinically relevant findings derived from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and selected ancillary studies appended to the primary trial. The chapter describes the participants, their recruitment and treatment, and the study design, primary outcomes, and clinically informative results. In particular, the chapter describes acute phase response and remission rates from each of the five treatment steps which entail antidepressant monotherapies and combinations, and psychotherapy alone or in combination with an antidepressant. In addition, longer-term outcomes beyond the 12 week acute trial are described for each treatment step. The treatment challenges described include patient retention and relapse, and longer-term follow-up. The chapter discusses the use of measurement-based care for delivering high-quality care, describes "treatment-resistant" depression and discusses its implications for clinical practice, and discusses the contributions of STAR*D to patient-oriented research and patient care.

DrugBank Data that Cites this Article

Drugs